Evidence map›Paper›PMID 40524652›Full record

ArticleJournal of veterinary internal medicine

Long-Term Clinical Response to Medical Treatment, Behavioral Therapy, or Their Combination in Cats With Hyperesthesia Syndrome.

Claudia Pauciulo, Stefania Uccheddu, Andrea Corda, Federica Biggio, Daniele Sebastian Corlazzoli, Marika Menchetti, Antonella Gallucci

Abstract read
In one paragraph

Article in Journal of veterinary internal medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claudia PauciuloVeterinary Neurology Center, Rome, Italy.
Stefania UcchedduBehavioral Medicine and Animal Welfare Division, San Marco Veterinary Clinic and Laboratory, Veggiano, Italy.
Andrea CordaDepartment of Veterinary Medicine, Veterinary Teaching Hospital, University of Sassari, Sassari, Italy.ORCID https://orcid.org/0000-0002-9771-4143
Federica BiggioVeterinary Neurological Center "La Fenice", Selargius, Italy.
Daniele Sebastian CorlazzoliVeterinary Neurology Center, Rome, Italy.
Marika MenchettiNeurology and Neurosurgery Division, San Marco Veterinary Clinic and Laboratory, Veggiano, Italy.
Antonella GallucciVeterinary Neurological Center "La Fenice", Selargius, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHyperesthesia syndrome (HS) is a common yet poorly understood condition in cats, with hypothesized neurological and behavioral causes and limited data on outcomes and treatment.

objectivesThis study aimed to describe the clinical outcomes and the treatment response of 28 cats with HS, managed through various therapeutic strategies. ANIMALS: Clinical records of 28 cats with HS and minimum of 1-year follow-up were reviewed.

methodsRetrospective, observational, descriptive study conducted on a case series of cats affected by HS. Sixteen cats (57%) received fluoxetine alone (Fluoxetine-only), seven (25%) were managed with behavioral modification and gabapentin or fluoxetine (Fluoxetine/Gabapentin + Behavior) and five (18%) were treated with behavioral modification alone (Behavior-only).

resultsAn episode-free period (EFP) ≥ 9 months was observed in 23 (82%) cats. Fifteen cats (94%) in the Fluoxetine-only group experienced an EFP of ≥ 9 months. Moreover, they had a shorter time to recovery (median [IQR] = 8 [3.5-18] days) compared to the Fluoxetine/Gabapentin + Behavior and Behavior-only groups (median [IQR] = 100 [90-210] and 60 [30-90] days, respectively). At the 1-year follow-up, 26 (93%) cats no longer had HS clinical signs and 14 (50%) were still under pharmacotherapy. Relapses were reported only in one case (4%).

conclusionsMost of the cat's diagnosed with HS, and managed through various therapeutic strategies, experienced an EFP of more than 9 months and showed absence of clinical signs at 1 year follow-up.

Indexed as

Behavior TherapyCat DiseasesFluoxetineAnimalsCatsFemaleGabapentinMaleRetrospective StudiesSelective Serotonin Reuptake InhibitorsSyndromeTreatment OutcomeFluoxetineGabapentinSelective Serotonin Reuptake Inhibitorsbehavioral modificationbehavioral therapycatsfelinefeline behaviorfeline neurologyfluoxetinehyperesthesia syndromerolling skin

Identifiers

PMID40524652
PMCPMC12171239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.